The Neuropharmacology of Cannabinoids: Developments in Medicine
A special issue of Biomedicines (ISSN 2227-9059). This special issue belongs to the section "Drug Discovery, Development and Delivery".
Deadline for manuscript submissions: 31 July 2024 | Viewed by 50
Special Issue Editor
Interests: psychiatry; psychopharmacology; addiction; drugs of abuse; toxicity
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The cannabis plant and cannabinoids have been of special interest to the scientific and medical communities over recent decades, since they target the endocannabinoid system and are implicated in health and disease processes. Cannabinoids have shown promise as therapeutics in cancer, inflammatory disease, and multiple sclerosis. Additionally, cannabinoids hold promise in mental health. Legislation has also propelled the research into cannabinoids in biomedical science, as many countries have largely legalized the sale and distribution of cannabis plant products. We kindly invite research groups and authors to publish articles on the neuropharmacology of cannabinoids, the endocannabinoid system, and implications for the medical sciences.
Dr. Tibor Markus Brunt
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- THC
- CBD
- cannabis
- endocannabinoid system
- therapeutic
- disease
- health
